Bicara Therapeutics finalizes Boston headquarters sublease with Wayfair LLC
The company disclosed a 35,090-square-foot sublease at 10 St. James Avenue, with a term that could begin as soon as October 2026 and run through September 2028.
SEC filing
Latest
4 stories
Tuesday, September 8
Tuesday, August 25
Tuesday, August 11
Bicara names successor CEO, reports pivotal trial on track for 2027 readout
Ryan Cohlhepp will succeed Claire Mazumdar as CEO in January 2027 as Bicara nears full enrollment in its head and neck cancer trial and reports $497.3 million in cash.
SEC filing
Tuesday, July 28
Bicara Therapeutics names two new directors as Mazumdar-Shaw exits board
The clinical-stage oncology company added Jeremy Bender and Christy Oliger to its board while founding director Kiran Mazumdar-Shaw resigned.
SEC filing